logo
  

Pre-market Movers: SWX, GWAV, CSSE, NVTA, SONO…

us pre market 053119 11aug22 lt

The following are some of the stocks making big moves in Thursday's pre-market trading (as of 07.25 A.M. ET).

In the Green

Greenwave Technology Solutions, Inc. (GWAV) is up over 29% at $4.61
Chicken Soup for the Soul Entertainment, Inc. (CSSE) is up over 24% at $18.41
Vacasa, Inc. (VCSA) is up over 19% at $3.64
VIZIO Holding Corp. (VZIO) is up over 11% at $11.60
AMTD Digital Inc. (HKD) is up over 10% at $240
Dingdong (Cayman) Limited (DDL) is up over 10% at $4.97
Aegon N.V. (AEG) is up over 9% at $5.07
Sky Harbour Group Corporation (SKYH) is up over 9% at $4.77
TransMedics Group, Inc. (TMDX) is up over 8% at $50.00
Archer Aviation Inc. (ACHR) is up over 8% at $4.58

In the Red

Southwest Gas Holdings, Inc. (SWX) is down over 89% at $8.02
Invitae Corporation (NVTA) is down over 20% at $6.85
Sonos, Inc. (SONO) is down over 19% at $18.25
Red Robin Gourmet Burgers, Inc. (RRGB) is down over 18% at $8.70
Traeger, Inc. (COOK) is down over 14% at $3.44
Sanofi (SNY) is down over 9% at $41.05
Bumble Inc. (BMBL) is down over 8% at $31.41
AppLovin Corporation (APP) is down over 6% at $37.74

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Apple Inc. plans to start using American-made processors from the new advanced chip factory in Phoenix, Arizona operated by chip giant Taiwan Semiconductor Manufacturing Co., according to its Chief Executive Officer Tim Cook. At an event in the factory in Arizona, which was attended by U.S. President Joe Biden, it was also announced that TSMC will invest $40 billion in the new factory. Lidl US has recalled its 8.4 oz Favorina branded Advent Calendar, i.e., Premium Chocolate with a Creamy Filling, citing potential Salmonella contamination, the U.S. Food and Drug Administration said. The products were available for sale at Lidl stores between October 12, 2022 and December 5, 2022. They will have a BEST IF USED BY year of 2023, and barcode number of 4056489516965. Vaccine partners Pfizer Inc. and BioNTech SE are seeking emergency use authorization or EUA from the U.S. Food and Drug Administration to offer their bivalent COVID-19 vaccine to children 6 months through 4 years of age. If authorized, the vaccine would be part of a primary series for children in this age group.
RELATED NEWS
Follow RTT